Cargando…
Utilization and Outcomes of Primary Prevention Implantable Cardioverter‐Defibrillators in Patients With Hypertrophic Cardiomyopathy
BACKGROUND: There is uncertainty about the appropriate use of primary prevention implantable cardioverter‐defibrillators (ICDs) among older patients with hypertrophic cardiomyopathy. METHODS AND RESULTS: Patients with hypertrophic cardiomyopathy who received a primary prevention ICD between 2010 and...
Autores principales: | Goldstein, Sarah A., Kennedy, Kevin F., Friedman, Daniel J., Al‐Khatib, Sana M., Wang, Andrew |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10492935/ https://www.ncbi.nlm.nih.gov/pubmed/37586066 http://dx.doi.org/10.1161/JAHA.122.029293 |
Ejemplares similares
-
Implantable cardioverter–defibrillator in hypertrophic cardiomyopathy
por: Sanchez, Diego Jimenez, et al.
Publicado: (2018) -
Role of Implantable Cardioverter Defibrillators in the Treatment of Hypertrophic Cardiomyopathy
por: Ghosh, Joydeep, et al.
Publicado: (2005) -
Left intraventricular pressure gradient in hypertrophic cardiomyopathy patients receiving implantable cardioverter-defibrillators for primary prevention
por: Yazaki, Kyoichiro, et al.
Publicado: (2021) -
Subcutaneous Implantable Cardioverter Defibrillator in Patients With Hypertrophic Cardiomyopathy: An Initial Experience
por: Weinstock, Jonathan, et al.
Publicado: (2016) -
Decision‐making regarding primary prevention implantable cardioverter‐defibrillators among older adults
por: Hess, Paul L., et al.
Publicado: (2019)